Special presentation and feedback session with NIAID's Peter Kim, Director of the Therapeutics Research Program in the Division of AIDS.



Questions include: What did we learn from the COVID response about NIAID-funded research (HIV, TB, emerging infectious diseases)? How should allocations be changed and pandemic responses optimized? What have we learned about HIV setbacks caused by COVID, and how should we fix them?